Drug Patent Expirations for the Week of August 14, 2022

AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…


New patent for Amicus Therap drug GALAFOLD

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are forty-one patents protecting this drug. This drug…
The post New patent for Amicus Therap drug GALAFOLD appeared first on D…


Biotechblog